Open Source Drug Discovery
Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
129
Total Open
Publications
73
Total
Citations
2K
Open Access
Percentage
57%
Total
Publications
129
Total Open
Publications
73
Total
Citations
2K
Breakdown
Publisher Open
25%
Both
29%
Other Platform Open
3%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
29
Hybrid 33%
23
No Guarantees 25%
17
Other Platform Open
Domain 85%
35
Public 20%
8
Institution 12%
5
Other Internet 12%
5
Preprint 7%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 34 |
Europe PMC | Domain | 23 |
Semantic Scholar | Public | 8 |
DOI | Other Internet | 4 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 2 |
University Computing Centre - Hrčak Portal of scientific journals of Croatia | Other Internet | 2 |
University College London - UCL Discovery | Institution | 2 |
Preprints | Preprint | 2 |
Unknown Repository | Other Internet | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |